Author:
Lee H. Y.,Lie D.,Lim K. S.,Thirumoorthy T.,Pang S. M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference5 articles.
1. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Eng J Med 350 (5):459–468
2. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733
3. Fogelman I, Blake GM. Strontium ranelate for the treatment of osteoporosis. BMJ 330(7505):1400–1401
4. O’Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006) Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev 4:CD005326
5. European Medicines Agency Press Office (2007) EMEA recommends changes in the product information for Protelos/Osseor due to the risk of severe hypersensitivity reactions. EMEA/417458/2007
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献